Effects of Long-term Administration of Low-dose FTY720 on Survival of Murine Cardiac Allograft
- Author:
- No author available
- Issue:
- 2
- DOI:
- 10.1007/s11596-012-0035-5
- Key Word:
- FTY720;immunosuppresant;heart transplantation;rejection;lymphocyte
Abstract： This study examined the effect of long-term administration of low-dose FTY720 on survival of murine cardiac allograft and the possible mechanism.Murine models of abdominal heterotopic heart transplantation were established.Low-dose FTY720 (0.3 mg/kg) was administrated to the animals 4 days before the transplantation of cardiac allografis until the occurrence of rejection or the observation terminals.The animals without FTY720 treatment and those with syngencic cardiac grafts transplanted served as controls.The mean survival time (MST) of grafts,and T lymphocyte subsets in gratis,peripheral blood and lymphoid organs were measured by histopathological examination or flow cytometry,and compared among groups.The results showed that the MST of allografts in FTY720-treated mice was more than 40 days,significantly longer than that in the untreated group (MST=8 days,P＜0.01).After the long-term administration of FTY720,the proportion of CD4+ and CD8+ lymphocytes in peripheral blood was diminished significantly,but the proportion ofCD4+ lymphocytes was increased in mesenteric lymph nodes (MLNs) and spleen.lmmunofluorescence staining revealcd that the infiltration of CD4+ and CD8+ lymphocytes in allografts was significantly inhibited after long-term administration of low-dose FTY720.It was concluded that low-dose long-term administration of FTY720 could promote T lymphocytes in lymphatic organs and decrease their infiltration in allografts,resulting in the inhibition of rejection and the long-term survival of allografts.
- [1]Boggi U,Vistoli F,Focosi D.Rejection of the kidney allograft.[J].2011,364(5).
- [2]Waltraud, Pfeilschifter,Bo?ena, Czech-Zechmeister,Marian, Sujak,etc.Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice.[J].2011,3.
- [3]Kusafuka T,Sugito K,Ikeda T,etc.Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes.[J].2007,39(10).
- [4]Nikolova Z,Hof R,Pinschewer D,etc.FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.[J].2001,33(1).
- [5]Myung-Ja Kwon,Ruiqing Wang,Jian Ma,etc.PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection.[J].2010,10(4).
- [6]Fairchild RL,Chen Y,Heeger PS,etc.Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival.[J].2006,176(2).
- [7]Kenneth M, Murphy,Steven L, Reiner.The lineage decisions of helper T cells.[J].2002,2(12).
- [8]Pappu R,Schwab SR,Cornelissen I,etc.Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.[J].2007,316(5822).
- [9]S, Suzuki,X K, Li,S, Enosawa,etc.A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes.[J].1996,89(4).
- [10]Silva HT Jr,Felipe CR,Abbud Filho M,etc.The emerging role of Brazil in clinical trial conduct for transplantation.[J].2011,11(7).
- [11]Schrama D,Thor Straten P,Becker JC,etc.Cytotoxic T cells.[J].2006,126(1).
- [12].Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection[J].1994,344(8920).
- [13]Strom TB,Sanchez Fueyo A.Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.[J].2011,140(1).
- [14]Foster CE,Tedesco Silva H,Lorber MI.FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study.[J].2009,23(5).
- [15]Rose AG,Burke MM,McManus B,etc.Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.[J].2005,24(11).
- [16]Suzanne, Mandala,Richard, Hajdu,James, Bergstrom,etc.Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.[J].2002,296(5566).
- [17]Lipp M,Nakano H,Hohenberger W,etc.CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720.[J].2001,194(12).
- [18]D I, Min,A P, Monaco.Complications associated with immunosuppressive therapy and their management.[J].1991,11(5).
- [19]Shinomiya T,Naoe S,Kakefuda T,etc.A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation.[J].1996,61(2).
- [20]J F, Borel.Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.[J].1990,41(3).
- [21]Quackenbush EJ,Forrest MJ,Xie JH,etc.Sphingosine-1-Phosphate Receptor Agonism Impairs the Efficiency of the Local Immune Response by Altering Trafficking of Naive and Antigen-Activated CD4(+) T Cells.[J].2003,170(7).
- [22]Schuetz M,Neumayer HH,Bohler T,etc.FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.[J].2004,19(3).
- [23]Li F,Li Q.Effects of different dose of FTY720 on lymphocyte cell cycle arrest in cardiac transplantation model of rats.[J].2010,32(4).
- [24]Ochsenbein AF,Brinkmann V,Pinschewer DD,etc.FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.[J].2000,164(11).
- [25]Bishop DK,Burrell BE.Th17 cells and transplant acceptance.[J].2010,90(9).